In addition, recent studies have shown that dermcidin, a stress induced protein, can inhibit glucose-induced insulin synthesis and result in hyperglycemia in patients with AMI and stress-induced type 1 diabetes27, 28. This evidence concerns the gene INS and Hyperglycemia.